nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—PTGER2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.135	0.135	CbGpPWpGaD
Alprostadil—PTGIR—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0912	0.0912	CbGpPWpGaD
Alprostadil—PTGER1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0912	0.0912	CbGpPWpGaD
Alprostadil—PTGIR—Endothelin Pathways—EDNRA—intracranial aneurysm	0.0845	0.0845	CbGpPWpGaD
Alprostadil—PTGIR—Endothelin Pathways—NOS3—intracranial aneurysm	0.0371	0.0371	CbGpPWpGaD
Alprostadil—PTGIR—Thromboxane A2 receptor signaling—NOS3—intracranial aneurysm	0.0243	0.0243	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—TIMP1—intracranial aneurysm	0.0242	0.0242	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0241	0.0241	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.023	0.023	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STARD13—intracranial aneurysm	0.0219	0.0219	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.0211	0.0211	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.0207	0.0207	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.0189	0.0189	CbGpPWpGaD
Alprostadil—PTGIR—Platelet homeostasis—NOS3—intracranial aneurysm	0.0186	0.0186	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0163	0.0163	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0163	0.0163	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.0157	0.0157	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—AGER—intracranial aneurysm	0.0152	0.0152	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STARD13—intracranial aneurysm	0.0148	0.0148	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STARD13—intracranial aneurysm	0.0148	0.0148	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.014	0.014	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.014	0.014	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SLC25A16—intracranial aneurysm	0.0126	0.0126	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.0107	0.0107	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—EDNRA—intracranial aneurysm	0.0106	0.0106	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.0106	0.0106	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SLC25A16—intracranial aneurysm	0.0105	0.0105	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—AGER—intracranial aneurysm	0.0105	0.0105	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.0102	0.0102	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TIMP1—intracranial aneurysm	0.00927	0.00927	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.0089	0.0089	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00808	0.00808	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.0079	0.0079	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CCL2—intracranial aneurysm	0.00776	0.00776	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ASAH1—intracranial aneurysm	0.00698	0.00698	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00688	0.00688	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00688	0.00688	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00601	0.00601	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00601	0.00601	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TIMP1—intracranial aneurysm	0.00553	0.00553	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00546	0.00546	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00546	0.00546	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00524	0.00524	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL2—intracranial aneurysm	0.00524	0.00524	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NCF1—intracranial aneurysm	0.00506	0.00506	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CST3—intracranial aneurysm	0.00482	0.00482	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00477	0.00477	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NCF1—intracranial aneurysm	0.00419	0.00419	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—NOS3—intracranial aneurysm	0.00418	0.00418	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL2—intracranial aneurysm	0.00398	0.00398	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NCF1—intracranial aneurysm	0.00341	0.00341	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NCF1—intracranial aneurysm	0.00341	0.00341	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00322	0.00322	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EDNRA—intracranial aneurysm	0.00322	0.00322	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00269	0.00269	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL2—intracranial aneurysm	0.00269	0.00269	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—intracranial aneurysm	0.00249	0.00249	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—intracranial aneurysm	0.00235	0.00235	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—intracranial aneurysm	0.0021	0.0021	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—intracranial aneurysm	0.00174	0.00174	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—intracranial aneurysm	0.00168	0.00168	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—intracranial aneurysm	0.00159	0.00159	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—intracranial aneurysm	0.00159	0.00159	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—intracranial aneurysm	0.00146	0.00146	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—intracranial aneurysm	0.00142	0.00142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—intracranial aneurysm	0.00142	0.00142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—intracranial aneurysm	0.00114	0.00114	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—intracranial aneurysm	0.00114	0.00114	CbGpPWpGaD
